Compare NUVB & XMTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUVB | XMTR |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.2B |
| IPO Year | N/A | 2021 |
| Metric | NUVB | XMTR |
|---|---|---|
| Price | $5.72 | $65.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 9 |
| Target Price | $10.89 | ★ $55.11 |
| AVG Volume (30 Days) | ★ 6.6M | 753.7K |
| Earning Date | 03-05-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $26,748,000.00 | ★ $642,780,000.00 |
| Revenue This Year | $636.92 | $26.71 |
| Revenue Next Year | $191.15 | $20.22 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1137.19 | 22.40 |
| 52 Week Low | $1.54 | $18.59 |
| 52 Week High | $9.75 | $69.26 |
| Indicator | NUVB | XMTR |
|---|---|---|
| Relative Strength Index (RSI) | 43.91 | 52.06 |
| Support Level | $5.51 | $56.93 |
| Resistance Level | $6.22 | $63.04 |
| Average True Range (ATR) | 0.36 | 3.69 |
| MACD | 0.07 | -0.20 |
| Stochastic Oscillator | 79.65 | 66.33 |
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.